Dr. Siontis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2015 - 2018
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2012 - 2015
University of Washington School of MedicineClass of 2012
Certifications & Licensure
MN State Medical License 2018 - 2025
MI State Medical License 2015 - 2020
IN State Medical License 2016 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- ABIMMedical Oncology
Clinical Trials
- Localized Leiomyosarcoma Biomarker Protocol Start of enrollment: 2023 Apr 26
- Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma Start of enrollment: 2019 Mar 27
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Outcomes of Scapular Osteosarcoma.Leilani Garayua-Cruz, Samuel E Broida, Steven I Robinson, Scott H Okuno, Thanh P Ho
Anticancer Research. 2025-01-01 - 3 citationsA Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.Scott M Schuetze, Karla V Ballman, Rachel Heise, Kristen N Ganjoo, Elizabeth J Davis
Clinical Cancer Research. 2024-10-15 - Management and Long-Term Outcomes of Patients With Hepatic Epithelioid Hemangioendothelioma.Tedy Sawma, Ahmer Sultan, Samer Abdulmoneim, Travis Grotz, Charles B Rosen
Journal of Surgical Oncology. 2024-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
